An Open-Label, Single-Treatment, Single-Period, Single Dose, Clinical Phase 1 Study to Assess the Safety and Tolerability of Tetanus Vaccine in Healthy, Adult Subjects in India

Journal of Evidence Based Medicine and Healthcare

doi 10.18410/jebmh/2019/43